Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0391 | ||||
| Gene Name | SLC51A | ||||
| Protein Name | Organic solute transporter subunit alpha | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
Modelled DT Structure Method: multi-sequence alignment based machine learning Detail: Structure Info |
||||
| Synonyms | OST-alpha; OSTA; OSTalpha; SLC51A; Solute carrier family 51 subunit alpha | ||||
| DT Family | Organic Solute Transporter (OST) Family ; | ||||
| Tissue Specificity | Widely expressed with a high expression inileum. Expressed in testis, colon, liver, small intestine, kidney,ovary and adrenal gland; and at low levels in heart, lung, brain,pituitary, thyroid gland, uterus, prostate, mammary gland and fat. | ||||
| Function | This transporter is essential component of the Ost-alpha/Ost-beta complex, a heterodimer that acts as the intestinal basolateral transporter responsible for bile acid export from enterocytes into portal blood. Efficiently transports the major species of bile acids. | ||||
| Endogenous Substrate(s) | Bile acid | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(α) Microbiota Influence of This DT |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(ε) Exogenous Modulation of This DT |
|||||
|
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
|
(β) Inter-species Structural Differences |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Full List of Drug(s) Transported by This DT |
|||||
|
Approved Drug |
Click to Show/Hide the Full List of Drug: 3 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
Digoxin
|
Approved | Drug Info | Arrhythmias | BC60-BC9Z | [1] |
|
Dinoprostone
|
Approved | Drug Info | Medical abortion | JA00.1 | [1] |
|
Estrone sulfate
|
Approved | Drug Info | Menopausal symptoms | MF32 | [1] |
|
Withdrawn, Discontinued or Preclinical Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
Taurocholic acid
|
Terminated | Drug Info | Type 2 diabetes | 5A11 | [1] |
| References | |||||
| 1 | Functional complementation between a novel mammalian polygenic transport complex and an evolutionarily ancient organic solute transporter, OSTalpha-OSTbeta. J Biol Chem. 2003 Jul 25;278(30):27473-82. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.